{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:04:48Z","timestamp":1792087488989,"version":"4.4.0"},"reference-count":258,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"U.S. Public Health Service","award":["R21AI156304"],"award-info":[{"award-number":["R21AI156304"]}]},{"name":"U.S. Public Health Service","award":["R01AI169865"],"award-info":[{"award-number":["R01AI169865"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Treatments for bacterial infections can be less effective due to toxicities, bacterial tolerance, or genetic resistance to antibacterial agents. The emphasis here is on combating genetic bacterial resistance to bacteriophages. Commonly described simply as phages, bacteriophages are the viruses of bacteria. As phage therapies, they are one of the oldest clinical treatments for bacterial infections. Thwarting bacterial evolution of resistance to phages, particularly during phage treatments, typically involves targeting more than one bacterial characteristic. This can be achieved serially, involving phage substitution after bacterial resistance has become problematic, something that is used especially during more personalized therapies. Substitution phages can be sourced in various ways. This includes as autophages, from phage banks, or via phage training\u2014all as considered here\u2014as well as through phage engineering. An alternative approach is preventing bacterial mutations from occurring at all. In addition, there is simultaneous targeting of multiple bacterial characteristics. These latter strategies include all of the following: using phages that target bacterial fitness or virulence determinants, employing individual phages that recognize multiple receptors, using phage cocktails, or applying phages in combination with antibiotics. This review discusses these different approaches for combating treatment resistance, highlighting various pros and cons.<\/jats:p>","DOI":"10.3390\/v17081094","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T09:56:42Z","timestamp":1754647002000},"page":"1094","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Phage Therapy: Combating Evolution of Bacterial Resistance to Phages"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9151-2375","authenticated-orcid":false,"given":"Stephen T.","family":"Abedon","sequence":"first","affiliation":[{"name":"Department of Microbiology, The Ohio State University, Mansfield, OH 44906, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e0147623","DOI":"10.1128\/jvi.01476-23","article-title":"Collateral sensitivity increases the efficacy of a rationally designed bacteriophage combination to control Salmonella enterica","volume":"98","author":"Acton","year":"2024","journal-title":"J. Virol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Harper, D.R., Abedon, S.T., Burrowes, B., and McConville, M. (2021). Structure and function of bacteriophages. Bacteriophages: Biology, Technology, Therapy, Springer Nature Switzerland AG.","DOI":"10.1007\/978-3-319-41986-2"},{"key":"ref_3","unstructured":"Hyman, P., and Abedon, S.T. (2018). Bacteriophage diversity. Viruses of Microorganisms, Caister Academic Press."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Kutter, E., and Sulakvelidze, A. (2005). Bacteriophage therapy in humans. Bacteriophages: Biology and Application, CRC Press.","DOI":"10.1201\/9780203491751.ch14"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"G\u00f3rski, A., Mi\u0119dzybrodzki, R., and Borysowski, J. (2019). Combining bacteriophages with other antibacterial agents to combat bacteria. Phage Therapy: A Practical Approach, Springer Nature.","DOI":"10.1007\/978-3-030-26736-0"},{"key":"ref_6","first-page":"1120","article-title":"Essais de th\u00e9rapeutique au moyen du bact\u00e9riophage du Staphylocoque","volume":"85","author":"Bruynoghe","year":"1921","journal-title":"Compt. Rend. Soc. Biol."},{"key":"ref_7","first-page":"226","article-title":"On the antibacterial action of cultures of a Penicillium, with special reference to their use in the isolation of B. influenzae","volume":"10","author":"Fleming","year":"1929","journal-title":"Brit. J. Exp. Path."},{"key":"ref_8","first-page":"12","article-title":"\u2018That\u2019s funny!\u2019: The discovery and development of penicillin","volume":"36","author":"Brown","year":"2009","journal-title":"Microbiol. Today"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1017\/S0025727300045026","article-title":"Paine and the earliest surviving clinical records of penicillin therapy","volume":"30","author":"Wainwright","year":"1986","journal-title":"Med. Hist."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(45)90682-9","article-title":"Battle casualties treated with penicllin","volume":"245","author":"Innes","year":"1945","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Aminov, R.I. (2010). A brief history of the antibiotic era: Lessons learned and challenges for the future. Front. Microbiol., 1.","DOI":"10.3389\/fmicb.2010.00134"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"426","DOI":"10.2105\/AJPH.2012.300693","article-title":"Rethinking antibiotic research and development: World War II and the penicillin collaborative","volume":"103","author":"Quinn","year":"2013","journal-title":"Am. J. Public Health"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1089\/fpd.2008.0242","article-title":"Kinetics of phage-mediated biocontrol of bacteria","volume":"6","author":"Abedon","year":"2009","journal-title":"Foodborne Pathog. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"G\u00f3rski, A., Mi\u0119dzybrodzki, R., and Borysowski, J. (2019). Phage Therapy: A Practical Approach, Springer Nature.","DOI":"10.1007\/978-3-030-26736-0"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Abedon, S.T., Danis-Wlodarczyk, K., and Alves, D.R. (2021). Phage therapy in the 21st Century: Is there modern, clinical evidence of phage-mediated clinical efficacy?. Pharmaceuticals, 14.","DOI":"10.3390\/ph14111157"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Marongiu, L., Burkard, M., Lauer, U.M., Hoelzle, L.E., and Venturelli, S. (2022). Reassessment of historical clinical trials supports the effectiveness of phage therapy. Clin. Microbiol Rev., 35.","DOI":"10.1128\/cmr.00062-22"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e0207121","DOI":"10.1128\/aac.02071-21","article-title":"Considerations for the use of phage therapy in clinical practice","volume":"66","author":"Suh","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Petrovic Fabijan, A., Iredell, J., Danis-Wlodarczyk, K., Kebriaei, R., and Abedon, S.T. (2023). Translating phage therapy into the clinic: Recent accomplishments but continuing challenges. PLoS Biol., 21.","DOI":"10.1371\/journal.pbio.3002119"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cell.2022.11.017","article-title":"Phage therapy: From biological mechanisms to future directions","volume":"186","author":"Strathdee","year":"2023","journal-title":"Cell"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e187996","DOI":"10.1172\/JCI187996","article-title":"Bacteriophage therapy for multidrug-resistant infections: Current technologies and therapeutic approaches","volume":"135","author":"Kim","year":"2025","journal-title":"J. Clin. Investig."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3181\/00379727-23-2801","article-title":"On variants of B. pestis caviae resistant to lysis by bacteriophage","volume":"23","author":"Bronfenbrenner","year":"1925","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Harper, D.R. (2006). Biological control by microorganisms. The Encyclopedia of Life Sciences, John Wiley & Sons.","DOI":"10.1038\/npg.els.0004334"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Harper, D.R. (2013). Biological control by microorganisms. eLS, John Wiley & Sons.","DOI":"10.1002\/9780470015902.a0000344.pub3"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Hyman, P., and Abedon, S.T. (2018). Viruses as biocontrol agents of microorganisms. Viruses of Microorganisms, Caister Academic Press.","DOI":"10.21775\/9781910190852.13"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Gildea, L., Ayariga, J.A., and Robertson, B.K. (2022). Bacteriophages as biocontrol agents in livestock food production. Microorganisms, 10.","DOI":"10.3390\/microorganisms10112126"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"112164","DOI":"10.1016\/j.plantsci.2024.112164","article-title":"Exploring the historical roots, advantages and efficacy of phage therapy in plant diseases management","volume":"346","author":"Haq","year":"2024","journal-title":"Plant Sci."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Ul Haq, I., Khan, M., and Khan, I. (2024). Phytopathological management through bacteriophages: Enhancing food security amidst climate change. J. Ind. Microbiol. Biotechnol., 51.","DOI":"10.1093\/jimb\/kuae031"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Czajkowski, R., Roca, A., and Matilla, M.A. (2025). Harnessing bacteriophages for sustainable crop protection in the face of climate change. Microb. Biotechnol., 18.","DOI":"10.1111\/1751-7915.70108"},{"key":"ref_29","first-page":"36","article-title":"Phage cocktails\u2014An emerging approach for the control of bacterial infection with major emphasis on foodborne pathogens","volume":"40","author":"Teklemariam","year":"2023","journal-title":"Biotechnol. Genet. Eng. Rev."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"105923","DOI":"10.1016\/j.micpath.2022.105923","article-title":"Emergent crisis of antibiotic resistance: A silent pandemic threat to 21st century","volume":"174","author":"Akram","year":"2023","journal-title":"Microb. Pathog."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/B978-0-12-394438-2.00003-7","article-title":"Clinical aspects of phage therapy","volume":"83","author":"Borysowski","year":"2012","journal-title":"Adv. Virus Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1089\/fpd.2016.2172","article-title":"Treatment of Salmonella-contaminated eggs and pork with a broad-spectrum, single bacteriophage: Assessment of efficacy and resistance development","volume":"13","author":"Hong","year":"2016","journal-title":"Foodborne Pathog. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Zhvania, P., Hoyle, N.S., Nadareishvili, L., Nizharadze, D., and Kutateladze, M. (2017). Phage therapy in a 16-year-old boy with Netherton syndrome. Front. Med., 4.","DOI":"10.3389\/fmed.2017.00094"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Oechslin, F. (2018). Resistance development to bacteriophages occurring during bacteriophage therapy. Viruses, 10.","DOI":"10.3390\/v10070351"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Rohde, C., Resch, G., Pirnay, J.-P., Blasdel, B.G., Debarbieux, L., Gelman, D., G\u00f3rski, A., Hazan, R., Huys, I., and Kakabadze, E. (2018). Expert opinion on three phage therapy related topics: Bacterial phage resistance, phage training and prophages in bacterial production strains. Viruses, 10.","DOI":"10.3390\/v10040178"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"G\u00f3rski, A., Mi\u0119dzybrodzki, R., and Borysowski, J. (2019). Bacterial resistance to phage and its impact on clinical therapy. Phage Therapy: A Practical Approach, Springer Nature.","DOI":"10.1007\/978-3-030-26736-0"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Zaldastanishvili, E., Leshkasheli, L., Dadiani, M., Nadareishvili, L., Askilashvili, L., Kvatadze, N., Goderdzishvili, M., Kutateladze, M., and Balarjishvili, N. (2021). Phage therapy experience at the Eliava Phage Therapy Center: Three cases of bacterial persistence. Viruses, 13.","DOI":"10.3390\/v13101901"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Abedon, S.T. (2023). Ecology and evolutionary biology of hindering phage therapy: The phage tolerance vs. phage resistance of bacterial biofilms. Antibiotics, 12.","DOI":"10.3390\/antibiotics12020245"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev-virology-012423-110530","article-title":"Developing phage therapy that overcomes the evolution of bacterial resistance","volume":"10","author":"Antani","year":"2023","journal-title":"Annu. Rev. Virol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"106004","DOI":"10.1016\/j.isci.2023.106004","article-title":"The dynamic interplay of bacteriophage, bacteria and the mammalian host during phage therapy","volume":"26","author":"Marchi","year":"2023","journal-title":"iScience"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"110209","DOI":"10.1016\/j.virol.2024.110209","article-title":"A game of resistance: War between bacteria and phages and how phage cocktails can be the solution","volume":"599","author":"Costa","year":"2024","journal-title":"Virology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/s41564-024-01705-x","article-title":"Personalized bacteriophage therapy outcomes for 100 consecutive cases: A multicentre, multinational, retrospective observational study","volume":"9","author":"Pirnay","year":"2024","journal-title":"Nat. Microbiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e00012-19","DOI":"10.1128\/MMBR.00012-19","article-title":"Pharmacologically aware phage therapy: Pharmacodynamic and pharmacokinetic obstacles to phage antibacterial action in animal and human bodies","volume":"83","author":"Abedon","year":"2019","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Styles, K.M., Brown, A.T., and Sagona, A.P. (2021). A review of using mathematical modeling to improve our understanding of bacteriophage, bacteria, and eukaryotic interactions. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.724767"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"101201","DOI":"10.1016\/j.coviro.2022.101201","article-title":"Mitigation of evolved bacterial resistance to phage therapy","volume":"53","author":"Turner","year":"2022","journal-title":"Curr. Opin. Virol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1089\/phage.2022.0036","article-title":"Phage therapy administration route, regimen, and need for supplementary antibiotics in patients with chronic suppurative lung disease","volume":"4","author":"Williams","year":"2023","journal-title":"Phage"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/bs.aivir.2021.07.004","article-title":"Advancing phage therapy through the lens of virus host-breadth and emergence potential","volume":"111","author":"Bono","year":"2021","journal-title":"Adv. Virus Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/978-1-0716-3549-0_23","article-title":"Overcoming bacteriophage resistance in phage therapy","volume":"2738","author":"Laanto","year":"2024","journal-title":"Methods Mol. Biol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Abedon, S.T., Danis-Wlodarczyk, K.M., and Wozniak, D.J. (2021). Phage cocktail development for bacteriophage therapy: Toward improving spectrum of activity breadth and depth. Pharmaceuticals, 14.","DOI":"10.3390\/ph14101019"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"aad3292","DOI":"10.1126\/science.aad3292","article-title":"Multidrug evolutionary strategies to reverse antibiotic resistance","volume":"351","author":"Baym","year":"2016","journal-title":"Science"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1007\/s00253-019-09629-x","article-title":"Bacteriophage-host arm race: An update on the mechanism of phage resistance in bacteria and revenge of the phage with the perspective for phage therapy","volume":"103","author":"Azam","year":"2019","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1099\/mic.0.000802","article-title":"Resistance is not futile: Bacterial \u2018innate\u2019 and CRISPR-Cas \u2018adaptive\u2019 immune systems","volume":"165","author":"Fineran","year":"2019","journal-title":"Microbiology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.chom.2019.01.009","article-title":"(Ph)ighting phages: How bacteria resist their parasites","volume":"25","author":"Rostol","year":"2019","journal-title":"Cell Host. Microbe"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1146\/annurev-virology-011620-040628","article-title":"Abortive infection: Bacterial suicide as an antiviral immune strategy","volume":"7","author":"Lopatina","year":"2020","journal-title":"Annu. Rev. Virol."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Ambroa, A., Blasco, L., Lopez, M., Pacios, O., Bleriot, I., Fernandez-Garcia, L., de Aledo, M.G., Ortiz-Cartagena, C., Millard, A., and Tomas, M. (2021). Genomic analysis of molecular bacterial mechanisms of resistance to phage infection. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.784949"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Egido, J.E., Costa, A.R., Aparicio-Maldonado, C., Haas, P.J., and Brouns, S.J.J. (2022). Mechanisms and clinical importance of bacteriophage resistance. FEMS Microbiol. Rev., 46.","DOI":"10.1093\/femsre\/fuab048"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Teklemariam, A.D., Al-Hindi, R.R., Qadri, I., Alharbi, M.G., Ramadan, W.S., Ayubu, J., Al-Hejin, A.M., Hakim, R.F., Hakim, F.F., and Hakim, R.F. (2023). The battle between bacteria and bacteriophages: A conundrum to their immune system. Antibiotics, 12.","DOI":"10.3390\/antibiotics12020381"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/eva.13518","article-title":"Comparison of bacterial suppression by phage cocktails, dual-receptor generalists, and coevolutionarily trained phages","volume":"16","author":"Borin","year":"2023","journal-title":"Evol. Appl."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"dlae017","DOI":"10.1093\/jacamr\/dlae017","article-title":"Improving phage therapy by evasion of phage resistance mechanisms","volume":"6","author":"Bleriot","year":"2024","journal-title":"JAC Antimicrob. Resist."},{"key":"ref_60","first-page":"569","article-title":"Results of bacteriophage treatment of suppurative bacterial infections in the years 1981\u20131986","volume":"35","year":"1987","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Harper, D.R., Abedon, S.T., Burrowes, B.H., and McConville, M.L. (2021). Clinical trials of bacteriophage therapeutics. Bacteriophages: Biology, Technology, Therapy, Springer Nature Switzerland AG.","DOI":"10.1007\/978-3-319-41986-2"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/S0140-6736(25)00737-8","article-title":"Implementation challenges of personalised phage therapy","volume":"405","author":"Djebara","year":"2025","journal-title":"Lancet"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1007\/s11095-010-0313-5","article-title":"The phage therapy paradigm: Pr\u00eat-\u00e0-porter or sur-mesure?","volume":"28","author":"Pirnay","year":"2011","journal-title":"Pharm. Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/s41591-019-0437-z","article-title":"Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus","volume":"25","author":"Dedrick","year":"2019","journal-title":"Nat. Med."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Gordillo Altamirano, F.L., and Barr, J.J. (2021). Screening for lysogen activity in therapeutically relevant bacteriophages. Bio. Protoc., 11.","DOI":"10.21769\/BioProtoc.3997"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Hyman, P., and Abedon, S.T. (2012). Prophage-induced changes in cellular cytochemistry and virulence. Bacteriophages in Health and Disease, CABI Press.","DOI":"10.1079\/9781845939847.0000"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.virol.2013.05.022","article-title":"Safety analysis of a Russian phage cocktail: From metaGenomic analysis to oral application in healthy human subjects","volume":"443","author":"McCallin","year":"2013","journal-title":"Virology"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s44259-025-00117-z","article-title":"Re-evaluating what makes a phage unsuitable for therapy","volume":"3","author":"Cook","year":"2025","journal-title":"NPJ Antimicrob. Resist."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4161\/bact.1.2.15680","article-title":"d\u2019H\u00e9relle. Preparation of Therapeutic Bacteriophages, Appendix 1 from: Le Ph\u00e9nom\u00e8ne de la Gu\u00e9rison dans les maladies infectieuses","volume":"1","author":"Kuhl","year":"2011","journal-title":"Bacteriophage"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Wright, R.C.T., Friman, V.P., Smith, M.C.M., and Brockhurst, M.A. (2018). Cross-resistance is modular in bacteria-phage interactions. PLoS Biol., 16.","DOI":"10.1371\/journal.pbio.2006057"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Trudelle, D.M., Bryan, D.W., Hudson, L.K., and Denes, T.G. (2019). Cross-resistance to phage infection in Listeria monocytogenes serotype 1\/2a mutants. Food Microbiol., 84.","DOI":"10.1016\/j.fm.2019.06.003"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e01652-19","DOI":"10.1128\/mBio.01652-19","article-title":"Resistance evolution against phage combinations depends on the timing and order of exposure","volume":"10","author":"Wright","year":"2019","journal-title":"MBio"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e00973-21","DOI":"10.1128\/mBio.00973-21","article-title":"Toward a phage cocktail for tuberculosis: Susceptibility and tuberculocidal action of mycobacteriophages against diverse Mycobacterium tuberculosis strains","volume":"12","author":"Dedrick","year":"2021","journal-title":"MBio"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Adler, B.A., Kazakov, A.E., Zhong, C., Liu, H., Kutter, E., Lui, L.M., Nielsen, T.N., Carion, H., Deutschbauer, A.M., and Mutalik, V.K. (2021). The genetic basis of phage susceptibility, cross-resistance and host-range in Salmonella. Microbiology, 167.","DOI":"10.1099\/mic.0.001126"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e9712","DOI":"10.1002\/ece3.9712","article-title":"Phage-resistant mutations impact bacteria susceptibility to future phage infections and antibiotic response","volume":"13","author":"McGee","year":"2023","journal-title":"Ecol. Evol."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Gu, J., Liu, X., Li, Y., Han, W., Lei, L., Yang, Y., Zhao, H., Gao, Y., Song, J., and Lu, R. (2012). A method for generation phage cocktail with great therapeutic potential. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0031698"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00253-017-8591-z","article-title":"A guard-killer phage cocktail effectively lyses the host and inhibits the development of phage-resistant strains of Escherichia coli","volume":"102","author":"Yu","year":"2018","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Li, C., Shi, T., Sun, Y., and Zhang, Y. (2022). A novel method to create efficient phage cocktails via use of phage-resistant bacteria. Appl. Environ. Microbiol., 88.","DOI":"10.1128\/aem.02323-21"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.resmic.2018.05.001","article-title":"Phage therapy against Achromobacter xylosoxidans lung infection in a patient with cystic fibrosis: A case report","volume":"169","author":"Hoyle","year":"2018","journal-title":"Res. Microbiol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1093\/cid\/ciz782","article-title":"Eradication of a multidrug-resistant, carbapenemase-producing Klebsiella pneumoniae isolate following oral and intra-rectal therapy with a custom made, lytic bacteriophage preparation","volume":"70","author":"Corbellino","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2174\/138920110790725302","article-title":"Phage therapy for plant disease control","volume":"11","author":"Balogh","year":"2010","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2217\/fmb.13.47","article-title":"Phage cocktails and the future of phage therapy","volume":"8","author":"Chan","year":"2013","journal-title":"Future Microbiol."},{"key":"ref_83","unstructured":"Sacher, J. (2023, February 11). Phage Banks Around the World. Available online: https:\/\/phage.directory\/capsid\/phage-banks."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"305","DOI":"10.14429\/dlsj.5.15760","article-title":"Applications of personalised phage therapy highlighting the importance of bacteriophage banks against emerging antimicrobial resistance","volume":"5","author":"Anand","year":"2020","journal-title":"Def. Life Sci. J."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Yerushalmy, O., Khalifa, L., Gold, N., Rakov, C., Alkalay-Oren, S., Adler, K., Ben-Porat, S., Kraitman, R., Gronovich, N., and Shulamit, G.K. (2020). The Israeli phage bank (IPB). Antibiotics, 9.","DOI":"10.3390\/antibiotics9050269"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"101208","DOI":"10.1016\/j.coviro.2022.101208","article-title":"Phage banks as potential tools to rapidly and cost-effectively manage antimicrobial resistance in the developing world","volume":"53","author":"Nagel","year":"2022","journal-title":"Curr. Opin. Virol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1089\/phage.2022.0010","article-title":"Phage therapy in Israel, past, present, and future","volume":"3","author":"Rimon","year":"2022","journal-title":"Phage"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41587-019-0133-z","article-title":"Phage therapy\u2019s latest makeover","volume":"37","author":"Schmidt","year":"2019","journal-title":"Nat. Biotech."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1089\/gen.40.02.13","article-title":"Phage therapy may combine efficacy and convenience: A father-son team rolls out PhageBank ATMs to help ensure that phage therapy gains currency","volume":"40","author":"LeMieux","year":"2020","journal-title":"Genet. Eng. Biotechnol. News"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/j.chom.2024.09.004","article-title":"Rapid design of bacteriophage cocktails to suppress the burden and virulence of gut-resident carbapenem-resistant Klebsiella pneumoniae","volume":"32","author":"Rotman","year":"2024","journal-title":"Cell Host Microbe"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Gibson, S.B., Green, S.I., Liu, C.G., Salazar, K.C., Clark, J.R., Terwilliger, A.L., Kaplan, H.B., Maresso, A.W., Trautner, B.W., and Ramig, R.F. (2019). Constructing and characterizing bacteriophage libraries for phage therapy of human infections. Front. Microbiol., 10.","DOI":"10.3389\/fmicb.2019.02537"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.copbio.2020.12.018","article-title":"Phage biobank: Present challenges and future perspectives","volume":"68","author":"Lin","year":"2021","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_93","unstructured":"Borysowski, J., Mi\u0119dzybrodzki, R., and G\u00f3rski, A. (2014). The first step to bacteriophage therapy: How to choose the correct phage. Phage Therapy: Current Research and Applications, Caister Academic Press."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2174\/1389201022666210426092002","article-title":"Bacteriophages: From isolation to application","volume":"23","author":"Abdelsattar","year":"2022","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1071\/MA19012","article-title":"Sourcing phages for compassionate use","volume":"40","author":"Sacher","year":"2019","journal-title":"Microbiol. Aust."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Harper, D.R., Abedon, S.T., Burrowes, B.H., and McConville, M. (2021). Phage therapy collaboration and compassionate use. Bacteriophages: Biology, Technology, Therapy, Springer Nature Switzerland AG.","DOI":"10.1007\/978-3-319-41986-2"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.chembiol.2022.06.003","article-title":"Cell-free production of personalized therapeutic phages targeting multidrug-resistant bacteria","volume":"29","author":"Emslander","year":"2022","journal-title":"Cell Chem. Biol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/978-1-0716-3658-9_25","article-title":"Cell-free synthesis and quantitation of bacteriophages","volume":"2760","author":"Levrier","year":"2024","journal-title":"Methods Mol. Biol."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Bretaudeau, L., Tremblais, K., Aubrit, F., Meichenin, M., and Arnaud, I. (2020). Good manufacturing practice (GMP) compliance for phage therapy medicinal products. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.01161"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Pirnay, J.-P. (2020). Phage therapy in the year 2035. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.01171"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s43586-024-00377-5","article-title":"Phage therapy","volume":"5","author":"Skurnik","year":"2025","journal-title":"Nature Rev. Methods Primers"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3390\/biologics1020005","article-title":"How to train your phage: The recent efforts in phage training","volume":"1","author":"Abdelsattar","year":"2021","journal-title":"Biologics"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"e2104592118","DOI":"10.1073\/pnas.2104592118","article-title":"Coevolutionary phage training leads to greater bacterial suppression and delays the evolution of phage resistance","volume":"118","author":"Borin","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"8572","DOI":"10.1038\/s41467-024-52595-w","article-title":"Targeting Pseudomonas aeruginosa biofilm with an evolutionary trained bacteriophage cocktail exploiting phage resistance trade-offs","volume":"15","author":"Kunisch","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-1-4939-7395-8_9","article-title":"Guidelines to compose an ideal bacteriophage cocktail","volume":"1693","author":"Merabishvili","year":"2018","journal-title":"Meth. Mol. Biol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"e02138-20","DOI":"10.1128\/AEM.02138-20","article-title":"Mutant and recombinant phages selected from in vitro coevolution conditions overcome phage-resistant Listeria monocytogenes","volume":"86","author":"Peters","year":"2020","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Loose, M., Moreno, D.S., Mutti, M., Hitzenhammer, E., Visram, Z., Dippel, D., Schertler, S., Tis\u00e1kov\u00e1, L.P., Wittmann, J., and Corsini, L. (2021). Natural bred \u03b52-phages have an improved host range and virulence against uropathogenic Escherichia coli over their ancestor phages. Antibiotics, 10.","DOI":"10.3390\/antibiotics10111337"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1111\/eva.13260","article-title":"Overcoming the growth-infectivity trade-off in a bacteriophage slows bacterial resistance evolution","volume":"14","author":"Zhang","year":"2021","journal-title":"Evol. Appl."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"S\u00e1ez Moreno, D., Visram, Z., Mutti, M., Restrepo-C\u00f3rdoba, M., Hartmann, S., Kremers, A.I., Ti\u0161\u00e1kov\u00e1, L., Schertler, S., Wittmann, J., and Kalali, B. (2021). \u03b52-Phages are naturally bred and have a vastly improved host range in Staphylococcus aureus over wild type phages. Pharmaceuticals, 14.","DOI":"10.3390\/ph14040325"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1111\/1462-2920.16106","article-title":"A lipopolysaccharide-dependent phage infects a pseudomonad phytopathogen and can evolve to evade phage resistance","volume":"24","author":"Warring","year":"2022","journal-title":"Environ. Microbiol."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Bull, J.J., Wichman, H.A., and Krone, S.M. (2022). Modeling the directed evolution of broad host range phages. Antibiotics, 11.","DOI":"10.1101\/2022.11.02.514838"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/jeb.12774","article-title":"Pre-adapting parasitic phages to a pathogen leads to increased pathogen clearance and lowered resistance evolution with Pseudomonas aeruginosa cystic fibrosis bacterial isolates","volume":"29","author":"Friman","year":"2016","journal-title":"J. Evol. Biol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"e1096995","DOI":"10.1080\/21597081.2015.1096995","article-title":"Development of expanded host range phage active on biofilms of multi-drug resistant Pseudomonas aeruginosa","volume":"6","author":"Mapes","year":"2016","journal-title":"Bacteriophage"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2307\/2410071","article-title":"Phage-mediated selection and the evolution and maintenance of restriction-modification","volume":"47","author":"Korona","year":"1993","journal-title":"Evolution"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4161\/bbug.2.1.13657","article-title":"Development of a broad-host-range phage cocktail for biocontrol","volume":"2","author":"Kelly","year":"2011","journal-title":"Bioeng. Bugs."},{"key":"ref_116","unstructured":"Furuta, Y., and Kobayashi, I. (2020, November 09). Restriction-modification systems as mobile epigenetic elements, Bacterial Integrative Mobile Genetic Elements, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK63963\/."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Kn\u00f6dlseder, N., Nevot, G., F\u00e1brega, M.J., Mir-Pedrol, J., Sanvicente-Garc\u00eda, M., Campama-Sanz, N., Paetzold, B., Lood, R., and G\u00fcell, M. (2022). Engineering selectivity of Cutibacterium acnes phages by epigenetic imprinting. PLoS Pathog., 18.","DOI":"10.1371\/journal.ppat.1010420"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1006\/jmbi.1994.1424","article-title":"Alterations of receptor specificities of coliphages of the T2 family","volume":"240","author":"Hashemolhosseini","year":"1994","journal-title":"J. Mol. Biol."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Hyman, P. (2017). Phage receptor. Reference Module in Life Sciences, Elsevier. Available online: https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/B9780128096338068849.","DOI":"10.1016\/B978-0-12-809633-8.06884-9"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"G\u00f3rski, A., Mi\u0119dzybrodzki, R., and Borysowski, J. (2019). Humoral immune response to phage-based therapeutics. Phage Therapy: A Practical Approach, Springer Nature.","DOI":"10.1007\/978-3-030-26736-0"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/s41591-021-01403-9","article-title":"Potent antibody-mediated neutralization limits bacteriophage treatment of a pulmonary Mycobacterium abscessus infection","volume":"27","author":"Dedrick","year":"2021","journal-title":"Nat. Med."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1038\/s41467-024-47192-w","article-title":"Phage-specific immunity impairs efficacy of bacteriophage targeting Vancomycin Resistant Enterococcus in a murine model","volume":"15","author":"Berkson","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2217\/fmb-2016-0156","article-title":"Antiphage activity of sera during phage therapy in relation to its outcome","volume":"12","author":"Letkiewicz","year":"2017","journal-title":"Future Microbiol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12223-020-00835-z","article-title":"Anti-phage serum antibody responses and the outcome of phage therapy","volume":"66","author":"Fortuna","year":"2021","journal-title":"Folia Microbiol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1128\/AAC.03786-14","article-title":"Bacteriophage-mediated control of a two-species biofilm formed by microorganisms causing catheter-associated urinary tract infections in an in vitro urinary catheter model","volume":"59","author":"Lehman","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Burrowes, B.H., Molineux, I.J., and Fralick, J.A. (2019). Directed in vitro evolution of therapeutic bacteriophages: The Appelmans protocol. Viruses, 11.","DOI":"10.3390\/v11030241"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"e0192321","DOI":"10.1128\/aac.01923-21","article-title":"Development of an anti-Acinetobacter baumannii biofilm phage cocktail: Genomic adaptation to the host","volume":"66","author":"Blasco","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"e0143923","DOI":"10.1128\/aac.01439-23","article-title":"The virtue of training: Extending phage host spectra against vancomycin-resistant Enterococcus faecium strains using the Appelmans method","volume":"68","author":"Lossouarn","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"199272","DOI":"10.1016\/j.virusres.2023.199272","article-title":"Appelmans protocol\u2014A directed in vitro evolution enables induction and recombination of prophages with expanded host range","volume":"339","author":"Vu","year":"2024","journal-title":"Virus Res."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s11262-024-02124-0","article-title":"Appelmans protocol for in vitro Klebsiella pneumoniae phage host range expansion leads to induction of the novel temperate linear plasmid prophage vB_KpnS-KpLi5","volume":"61","author":"Jakob","year":"2025","journal-title":"Virus Genes"},{"key":"ref_131","first-page":"163","article-title":"Der Einflu\u00df ausgew\u00e4hlter Herbicide auf Bakteriophagen und Escherichia coli [The action of selected herbicides on bacteriophages and Escherichia coli (author\u2019s transl)]","volume":"132","author":"Toure","year":"1977","journal-title":"Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene"},{"key":"ref_132","unstructured":"Appelmans, R., and Abedon, S.T. (2025, June 29). Le dosage du Bact\u00e9riophage, Note de R. Appelmans, Pr\u00e9sent\u00e9e Par R. Bruynoghe, R\u00e9union de la Soci\u00e9t\u00e9 Belge de Biologie, 1921, pp. 1098\u20131099, a Google Translation. Available online: https:\/\/asmallerflea.org\/2024\/12\/23\/le-dosage-du-bacteriophage-note-de-r-appelmans-presentee-par-r-bruynoghe-reunion-de-la-societe-belge-de-biologie-1921-pp-1098-1099-a-google-translation\/."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.copbio.2020.11.003","article-title":"Enhancing phage therapy through synthetic biology and genome engineering","volume":"68","author":"Lenneman","year":"2020","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Guo, D., Chen, J., Zhao, X., Luo, Y., Jin, M., Fan, F., Park, C., Yang, X., Sun, C., and Yan, J. (2021). Genetic and chemical engineering of phages for controlling multidrug-resistant bacteria. Antibiotics, 10.","DOI":"10.3390\/antibiotics10020202"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s40259-021-00480-z","article-title":"Engineered bacteriophage therapeutics: Rationale, challenges and future","volume":"35","year":"2021","journal-title":"BioDrugs."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.copbio.2020.09.005","article-title":"Genetic manipulation of phages for therapy using BRED","volume":"68","author":"Payaslian","year":"2021","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1021\/acssynbio.1c00319","article-title":"Directed evolution of replication-competent double-stranded DNA bacteriophage toward new host specificity","volume":"11","author":"Liang","year":"2022","journal-title":"ACS Synth. Biol."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Hussain, W., Yang, X., Ullah, M., Wang, H., Aziz, A., Xu, F., Asif, M., Ullah, M.W., and Wang, S. (2023). Genetic engineering of bacteriophages: Key concepts, strategies, and applications. Biotechnol. Adv., 64.","DOI":"10.1016\/j.biotechadv.2023.108116"},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Anastassopoulou, C., Tsakri, D., Panagiotopoulos, A.-P., Saldari, C., Sagona, A.P., and Tsakris, A. (2025). Armed phages: A new weapon in the battle against antimicrobial resistance. Viruses, 17.","DOI":"10.3390\/v17070911"},{"key":"ref_140","unstructured":"Charles, C. (1930). The Bacteriophage and its Clinical Application, Thomas Publisher."},{"key":"ref_141","unstructured":"Coffey, A., and Buttimer, C. (2020). Phage therapy: The pharmacology of antibacterial viruses. Exploitation of Bacteriophages for Biocontrol and Therapeutics, Caister Academic Press."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.addr.2018.06.018","article-title":"Use of phage therapy to treat long-standing, persistent, or chronic bacterial infections","volume":"145","author":"Abedon","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Abedon, S.T. (2008). Introduction to phage evolutionary biology. Bacteriophage Ecology, Cambridge University Press.","DOI":"10.1017\/CBO9780511541483"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/genetics\/28.6.491","article-title":"Mutations of bacteria from virus sensitivity to virus resistance","volume":"28","author":"Luria","year":"1943","journal-title":"Genetics"},{"key":"ref_145","unstructured":"Abedon, S.T. (2025, June 29). Monitoring the Ecology vs. Evolutionary Biology of Phage Resistance: A Tale of Two Precisions. Available online: https:\/\/asmallerflea.org\/2022\/07\/21\/monitoring-the-ecology-vs-evolutionary-biology-of-phage-resistance-a-tale-of-two-precisions\/."},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Cui, L., Watanabe, S., Miyanaga, K., Kiga, K., Sasahara, T., Aiba, Y., Tan, X.E., Veeranarayanan, S., Thitiananpakorn, K., and Nguyen, H.M. (2024). A comprehensive review on phage therapy and phage-based drug development. Antibiotics, 13.","DOI":"10.20944\/preprints202408.1879.v1"},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Mayorga-Ramos, A., Carrera-Pacheco, S.E., Barba-Ostria, C., and Guaman, L.P. (2024). Bacteriophage-mediated approaches for biofilm control. Front. Cell Infect. Microbiol., 14.","DOI":"10.3389\/fcimb.2024.1428637"},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Vera-Mansilla, J., Silva-Valenzuela, C.A., Sanchez, P., and Molina-Quiroz, R.C. (2023). Bacteriophages potentiate the effect of antibiotics by eradication of persister cells and killing of biofilm-forming cells. Res. Microbiol., 174.","DOI":"10.1016\/j.resmic.2023.104083"},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Abedon, S.T., Danis-Wlodarczyk, K.M., Wozniak, D.J., and Sullivan, M.B. (2021). Improving phage-biofilm in vitro experimentation. Viruses, 13.","DOI":"10.3390\/v13061175"},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Danis-Wlodarczyk, K.M., Wozniak, D.J., and Abedon, S.T. (2021). Treating bacterial infections with bacteriophage-based enzybiotics: In vitro, in vivo and clinical application. Antibiotics, 10.","DOI":"10.3390\/antibiotics10121497"},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Chan, B.K., Sistrom, M., Wertz, J.E., Kortright, K.E., Narayan, D., and Turner, P.E. (2016). Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa. Sci. Rep., 6.","DOI":"10.1038\/srep26717"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/emph\/eoy005","article-title":"Phage treatment of an aortic graft infected with Pseudomonas aeruginosa","volume":"1","author":"Chan","year":"2018","journal-title":"Evol. Med. Pub. Health"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"11207","DOI":"10.1073\/pnas.1919888117","article-title":"Pleiotropy complicates a trade-off between phage resistance and antibiotic resistance","volume":"117","author":"Burmeister","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"9987","DOI":"10.1038\/s41467-024-53994-9","article-title":"A blueprint for broadly effective bacteriophage-antibiotic cocktails against bacterial infections","volume":"15","author":"Kim","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/nyas.14533","article-title":"Phage-antibiotic combinations: A promising approach to constrain resistance evolution in bacteria","volume":"1496","author":"North","year":"2021","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/mlf2.70003","article-title":"Leveraging collateral sensitivity to counteract the evolution of bacteriophage resistance in bacteria","volume":"4","author":"Mu","year":"2025","journal-title":"mLife"},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Abedon, S.T. (2022). Pleiotropic costs of phage resistance. Bacteriophages as Drivers of Evolution: An Evolutionary Ecological Perspective, Springer.","DOI":"10.1007\/978-3-030-94309-7"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1046\/j.1461-0248.2000.00161.x","article-title":"Linking genetic change to community evolution: Insights from studies of bacteria and bacteriophage","volume":"3","author":"Bohannan","year":"2000","journal-title":"Ecol. Lett."},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Cairns, J., Becks, L., Jalasvuori, M., and Hiltunen, T. (2017). Sublethal streptomycin concentrations and lytic bacteriophage together promote resistance evolution. Philos. Trans. R. Soc. Lond. B Biol. Sci., 372.","DOI":"10.1098\/rstb.2016.0040"},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Mahmud, H.A., and Wakeman, C.A. (2024). Navigating collateral sensitivity: Insights into the mechanisms and applications of antibiotic resistance trade-offs. Front. Microbiol., 15.","DOI":"10.3389\/fmicb.2024.1478789"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"7723","DOI":"10.1111\/1462-2920.15476","article-title":"The evolutionary trade-offs in phage-resistant Klebsiella pneumoniae entail cross-phage sensitization and loss of multidrug resistance","volume":"23","author":"Markwitz","year":"2021","journal-title":"Environ. Microbiol."},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Smug, B.J., Majkowska-Skrobek, G., and Drulis-Kawa, Z. (2022). PhREEPred: Phage resistance emergence prediction web tool to foresee encapsulated bacterial escape from phage cocktail treatment. J. Mol. Biol., 434.","DOI":"10.1016\/j.jmb.2022.167670"},{"key":"ref_163","first-page":"307","article-title":"Successful treatment of experimental Escherichia coli infections in mice using phage: Its general superiority over antibiotics","volume":"128","author":"Smith","year":"1982","journal-title":"J. Gen. Microbiol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1086\/285884","article-title":"Phage therapy revisited: The population biology of a bacterial infection and its treatment with bacteriophage and antibiotics","volume":"147","author":"Levin","year":"1996","journal-title":"Am. Nat."},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Le\u00f3n, M., and Bast\u00edas, R. (2015). Virulence reduction in bacteriophage resistant bacteria. Front. Microbiol., 6.","DOI":"10.3389\/fmicb.2015.00343"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"5806","DOI":"10.1128\/AAC.02877-15","article-title":"Personalized therapeutic cocktail of wild environmental phages rescues mice from Acinetobacter baumannii wound infections","volume":"60","author":"Regeimbal","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"e0111324","DOI":"10.1128\/jvi.01113-24","article-title":"Variable fitness effects of bacteriophage resistance mutations in Escherichia coli: Implications for phage therapy","volume":"98","author":"Gaborieau","year":"2024","journal-title":"J. Virol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"e0142923","DOI":"10.1128\/aac.01429-23","article-title":"Host immunity involvement in the outcome of phage therapy against hypervirulent Klebsiella pneumoniae infections","volume":"68","author":"Tang","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"e03303-24","DOI":"10.1128\/spectrum.03303-24","article-title":"Insertion sequence-mediated phage resistance contributes to attenuated colonization of cytolytic Enterococcus faecalis variants in the gut","volume":"13","author":"Fujiki","year":"2025","journal-title":"Microbiol. Spectr."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"e00758-18","DOI":"10.1128\/AAC.00758-18","article-title":"Loss-of-function mutations in epaR confer resistance to \u03d5NPV1 Infection in Enterococcus faecalis OG1RF","volume":"62","author":"Ho","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/emph\/eoaa026","article-title":"Phage steering of antibiotic-resistance evolution in the bacterial pathogen, Pseudomonas aeruginosa","volume":"2020","author":"Gurney","year":"2020","journal-title":"Evol. Med. Public Health"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"e00143-21","DOI":"10.1128\/AAC.00143-21","article-title":"Lytic bacteriophages facilitate antibiotic sensitization of Enterococcus faecium","volume":"65","author":"Canfield","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41564-020-00830-7","article-title":"Bacteriophage-resistant Acinetobacter baumannii are resensitized to antimicrobials","volume":"6","author":"Forsyth","year":"2021","journal-title":"Nat. Microbiol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1080\/22221751.2021.2002671","article-title":"Colistin-phage combinations decrease antibiotic resistance in Acinetobacter baumannii via changes in envelope architecture","volume":"10","author":"Wang","year":"2021","journal-title":"Emerg. Microbes. Infect."},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Coyne, A.J.K., Stamper, K., Kebriaei, R., Holger, D.J., El Ghali, A., Morrisette, T., Biswas, B., Wilson, M., Deschenes, M.V., and Canfield, G.S. (2022). Phage cocktails with daptomycin and ampicillin eradicates biofilm-embedded multidrug-resistant Enterococcus faecium with preserved phage susceptibility. Antibiotics, 11.","DOI":"10.3390\/antibiotics11091175"},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"Diallo, K., and Dublanchet, A. (2022). Benefits of combined phage-antibiotic therapy for the control of antibiotic-resistant bacteria: A literature review. Antibiotics, 11.","DOI":"10.3390\/antibiotics11070839"},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Gao, D., Ji, H., Wang, L., Li, X., Hu, D., Zhao, J., Wang, S., Tao, P., Li, X., and Qian, P. (2022). Fitness trade-offs in phage cocktail-resistant Salmonella enterica serovar Enteritidis results in increased antibiotic susceptibility and reduced virulence. Microbiol. Spectr., 10.","DOI":"10.1128\/spectrum.02914-22"},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Fujiki, J., Nakamura, K., Nakamura, T., and Iwano, H. (2023). Fitness trade-offs between phage and antibiotic sensitivity in phage-resistant variants: Molecular action and insights into clinical applications for phage therapy. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242115628"},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"Chen, L.K., Kuo, S.C., Chang, K.C., Cheng, C.C., Yu, P.Y., Chang, C.H., Chen, T.Y., and Tseng, C.C. (2017). Clinical antibiotic-resistant Acinetobacter baumannii strains with higher susceptibility to environmental phages than antibiotic-sensitive strains. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-06688-w"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"e01609-19","DOI":"10.1128\/AAC.01609-19","article-title":"Colistin-resistance-mediated bacterial surface modification sensitizes phage infection","volume":"63","author":"Hao","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/genetics\/30.2.119","article-title":"Bacteriophage-resistant mutants in Escherichia coli","volume":"30","author":"Demerec","year":"1945","journal-title":"Genetics"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1752-4571.2011.00236.x","article-title":"Phages limit the evolution of bacterial antibiotic resistance in experimental microcosms","volume":"5","author":"Zhang","year":"2012","journal-title":"Evol. Appl."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/eva.12136","article-title":"Exposure to phages has little impact on the evolution of bacterial antibiotic resistance on drug concentration gradients","volume":"7","author":"Zhang","year":"2014","journal-title":"Evol. Appl."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/s41587-019-0328-3","article-title":"Phage combination therapies for bacterial wilt disease in tomato","volume":"37","author":"Wang","year":"2019","journal-title":"Nat. Biotech."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"e00926-19","DOI":"10.1128\/IAI.00926-19","article-title":"Fitness trade-offs resulting from bacteriophage resistance potentiate synergistic antibacterial strategies","volume":"88","author":"Mangalea","year":"2020","journal-title":"Infect. Immun."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1086\/284364","article-title":"Constraints on the coevolution of bacteria and virulent phage: A model, some experiments, and predictions for natural communities","volume":"125","author":"Lenski","year":"1985","journal-title":"Am. Nat."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.tim.2019.10.007","article-title":"Steering phages to combat bacterial pathogens","volume":"28","author":"Gurney","year":"2020","journal-title":"Trends Microbiol."},{"key":"ref_188","doi-asserted-by":"crossref","unstructured":"Czerwinski, S., and Gurney, J. (2025). Phage steering in the presence of a competing bacterial pathogen. Microbiol. Spectr., 13.","DOI":"10.1128\/spectrum.02882-24"},{"key":"ref_189","unstructured":"Harper, D.R., Abedon, S.T., Burrowes, B.H., and McConville, M. (2021). Bacteria-phage antagonistic coevolution and the implications for phage therapy. Bacteriophages: Biology, Technology, Therapy, Springer Nature Switzerland AG."},{"key":"ref_190","doi-asserted-by":"crossref","unstructured":"Fujiki, J., Nakamura, K., Ishiguro, Y., and Iwano, H. (2024). Using phage to drive selections toward restoring antibiotic sensitivity in Pseudomonas aeruginosa via chromosomal deletions. Front. Microbiol., 15.","DOI":"10.3389\/fmicb.2024.1401234"},{"key":"ref_191","doi-asserted-by":"crossref","unstructured":"Olszak, T., Augustyniak, D., Garcia-Romero, I., Markwitz, P., Gula, G., Molinaro, A., Valvano, M.A., and Drulis-Kawa, Z. (2024). Phage treatment of Pseudomonas aeruginosa yields a phage-resistant population with different susceptibility to innate immune responses and mild effects on metabolic profiles. Microbiol. Res., 282.","DOI":"10.1016\/j.micres.2024.127609"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.chom.2017.06.018","article-title":"Synergy between the host immune system and bacteriophage is essential for successful phage therapy against an acute respiratory pathogen","volume":"22","author":"Roach","year":"2017","journal-title":"Cell Host Microbe"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/genetics\/107.1.1","article-title":"Two-step resistance by Escherichia coli B to bacteriophage T2","volume":"107","author":"Lenski","year":"1984","journal-title":"Genetics"},{"key":"ref_194","first-page":"724","article-title":"Host range mutants of bacteriophage Ox2 can use two different outer membrane proteins of Escherichia coli K-12 as receptors","volume":"159","author":"Morona","year":"1984","journal-title":"J. Bacteriol."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1126\/science.1067467","article-title":"Reverse transcriptase-mediated tropism switching in Bordetella bacteriophage","volume":"295","author":"Liu","year":"2002","journal-title":"Science"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"10384","DOI":"10.1128\/JVI.00801-12","article-title":"A multivalent adsorption apparatus explains the broad host range of phage phi92: A comprehensive genomic and structural analysis","volume":"86","author":"Schwarzer","year":"2012","journal-title":"J. Virol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.tim.2018.08.006","article-title":"Molecular and evolutionary determinants of bacteriophage host range","volume":"27","author":"Nobrega","year":"2019","journal-title":"Trends Microbiol."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1128\/jb.151.2.718-722.1982","article-title":"Roles of lipopolysaccharide and outer membrane protein ompC of Escherichia coli K-12 in the receptor function for bacteriophage T4","volume":"151","author":"Yu","year":"1982","journal-title":"J. Bacteriol."},{"key":"ref_199","doi-asserted-by":"crossref","unstructured":"Rojero, M., Weaver-Rosen, M., and Serwer, P. (2025). Bypassing evolution of bacterial resistance to phages: The example of hyper-aggressive phage 0524phi7-1. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26072914"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1126\/science.1214449","article-title":"Repeatability and contingency in the evolution of a key innovation in phage lambda","volume":"335","author":"Meyer","year":"2012","journal-title":"Science"},{"key":"ref_201","doi-asserted-by":"crossref","unstructured":"Calendar, R. (1988). Phage Mu. The Bacteriophages. Volume 1, Plenum Press. [1st ed.].","DOI":"10.1007\/978-1-4684-5424-6"},{"key":"ref_202","unstructured":"Calendar, R., and Abedon, S.T. (2006). The bacteriophage Mu. The Bacteriophages, Oxford University Press. [2nd ed.]."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1089\/phage.2022.0019","article-title":"Further considerations on how to improve phage therapy experimentation, practice, and reporting: Pharmacodynamics perspectives","volume":"3","author":"Abedon","year":"2022","journal-title":"Phage"},{"key":"ref_204","doi-asserted-by":"crossref","unstructured":"Niu, Y.D., Liu, H., Du, H., Meng, R., Sayed, M.E., Wang, G., McAllister, T.A., and Stanford, K. (2021). Efficacy of individual bacteriophages does not predict efficacy of bacteriophage cocktails for control of Escherichia coli O157. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.616712"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s00253-003-1438-9","article-title":"Toward rational control of Escherichia coli O157:H7 by a phage cocktail","volume":"64","author":"Tanji","year":"2004","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-394805-2.00001-4","article-title":"Phage therapy pharmacology: Phage cocktails","volume":"78","author":"Chan","year":"2012","journal-title":"Adv. Appl. Microbiol."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"e590","DOI":"10.7717\/peerj.590","article-title":"Synergy as a rationale for phage therapy using phage cocktails","volume":"2","author":"Schmerer","year":"2014","journal-title":"PeerJ"},{"key":"ref_208","doi-asserted-by":"crossref","unstructured":"Molina, F., Simancas, A., Ramirez, M., Tabla, R., Roa, I., and Rebollo, J.E. (2021). A new pipeline for designing phage cocktails based on phage-bacteria infection networks. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.564532"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.coviro.2021.12.011","article-title":"Shopping for phages? Unpacking design rules for therapeutic phage cocktails","volume":"52","author":"Lood","year":"2022","journal-title":"Curr. Opin. Virol."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/bs.pmbts.2023.04.007","article-title":"Phage and phage cocktails formulations","volume":"200","author":"Mani","year":"2023","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"122594","DOI":"10.1016\/j.watres.2024.122594","article-title":"Making waves: Intelligent phage cocktail design, a pathway to precise microbial control in water systems","volume":"268","author":"Hegarty","year":"2025","journal-title":"Water Res."},{"key":"ref_212","doi-asserted-by":"crossref","unstructured":"Marchi, J., Minh, C.N.N., Debarbieux, L., and Weitz, J.S. (2025). Multi-strain phage induced clearance of bacterial infections. PLoS Comput. Biol., 21.","DOI":"10.1371\/journal.pcbi.1012793"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/nrmicro822","article-title":"Population and evolutionary dynamics of phage therapy","volume":"2","author":"Levin","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_214","doi-asserted-by":"crossref","unstructured":"Casey, E., van Sinderen, D., and Mahony, J. (2018). In vitro characteristics of phages to guide \u2018real life\u2019 phage therapy suitability. Viruses, 10.","DOI":"10.3390\/v10040163"},{"key":"ref_215","unstructured":"Abedon, S.T. (2025, June 29). Phage Cocktail Optimizer. Available online: http:\/\/www.phage-therapy.org\/calculators\/cocktail_optimizer.html."},{"key":"ref_216","doi-asserted-by":"crossref","unstructured":"D\u00edaz-Gali\u00e1n, M.V., Vega-Rodr\u00edguez, M.A., and Molina, F. (2022). PhageCocktail: An R package to design phage cocktails from experimental phage-bacteria infection networks. Comput. Methods Programs Biomed., 221.","DOI":"10.1016\/j.cmpb.2022.106865"},{"key":"ref_217","doi-asserted-by":"crossref","unstructured":"Menor-Flores, M., Vega-Rodr\u00edguez, M.A., and Molina, F. (2022). Computational design of phage cocktails based on phage-bacteria infection networks. Comput. Biol. Med., 142.","DOI":"10.1016\/j.compbiomed.2021.105186"},{"key":"ref_218","doi-asserted-by":"crossref","unstructured":"Wright, R.C.T., Friman, V.P., Smith, M.C.M., and Brockhurst, M.A. (2021). Functional diversity increases the efficacy of phage combinations. Microbiology, 167.","DOI":"10.1099\/mic.0.001110"},{"key":"ref_219","doi-asserted-by":"crossref","unstructured":"Chen, H., Liu, H., Gong, Y., Dunstan, R.A., Ma, Z., Zhou, C., Zhao, D., Tang, M., Lithgow, T., and Zhou, T. (2024). A Klebsiella-phage cocktail to broaden the host range and delay bacteriophage resistance both in vitro and in vivo. NPJ. Biofilms. Microbiomes, 10.","DOI":"10.1038\/s41522-024-00603-8"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3934\/microbiol.2017.3.649","article-title":"Active bacteriophage biocontrol and therapy on sub-millimeter scales towards removal of unwanted bacteria from foods and microbiomes","volume":"3","author":"Abedon","year":"2017","journal-title":"AIMS Microbiol."},{"key":"ref_221","doi-asserted-by":"crossref","unstructured":"Li, G., Leung, C.Y., Wardi, Y., Debarbieux, L., and Weitz, J.S. (2020). Optimizing the timing and composition of therapeutic phage cocktails: A control-theoretic approach. Bull. Math Biol., 82.","DOI":"10.1007\/s11538-020-00751-w"},{"key":"ref_222","doi-asserted-by":"crossref","unstructured":"Yang, Y., Shen, W., Zhong, Q., Chen, Q., HE, X., Baker, J.L., Xiong, K., Jin, X., Wang, J., and Hu, F. (2020). Development of a bacteriophage cocktail to constrain the emergence of phage-resistant Pseudomonas aeruginosa. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.00327"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1080\/22221751.2021.1902754","article-title":"Pre-optimized phage therapy on secondary Acinetobacter baumannii infection in four critical COVID-19 patients","volume":"10","author":"Wu","year":"2021","journal-title":"Emerg. Microbes Infect."},{"key":"ref_224","unstructured":"Abedon, S.T. (2025, June 29). Phage Cross-Resistance Avoider. Available online: http:\/\/www.phage-therapy.org\/calculators\/xresistance_avoider.html."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"12106","DOI":"10.1073\/pnas.94.22.12106","article-title":"Evaluating treatment protocols to prevent resistance","volume":"94","author":"Bonhoeffer","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.mib.2011.08.003","article-title":"Combination therapies for combating antimicrobial resistance","volume":"14","author":"Fischbach","year":"2011","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"156","DOI":"10.4065\/mcp.2010.0639","article-title":"General principles of antimicrobial therapy","volume":"86","author":"Leekha","year":"2011","journal-title":"Mayo Clin. Proc."},{"key":"ref_228","doi-asserted-by":"crossref","unstructured":"REX Consortium (2013). Heterogeneity of selection and the evolution of resistance. Trends Ecol. Evol., 28, 110\u2013118.","DOI":"10.1016\/j.tree.2012.09.001"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/14740338.2021.1887135","article-title":"Risks and benefits of reducing the number of drugs to treat HIV-1 infection","volume":"20","author":"Cadinanos","year":"2021","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.tim.2015.12.011","article-title":"Evolutionary rationale for phages as complements of antibiotics","volume":"24","author":"Hochberg","year":"2016","journal-title":"Trends Microbiol."},{"key":"ref_231","doi-asserted-by":"crossref","unstructured":"Tagliaferri, T.L., Jansen, M., and Horz, H.P. (2019). Fighting pathogenic bacteria on two fronts: Phages and antibiotics as combined strategy. Front. Cell. Infect. Microbiol., 9.","DOI":"10.3389\/fcimb.2019.00022"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/phar.2358","article-title":"Bacteriophage therapeutics: A primer for clinicians on phage-antibiotic combinations","volume":"40","author":"Morrisette","year":"2020","journal-title":"Pharmacotherapy"},{"key":"ref_233","first-page":"e00756-19","article-title":"Quantitative models of phage-antibiotic combination therapy","volume":"5","author":"Leung","year":"2020","journal-title":"mSystems"},{"key":"ref_234","doi-asserted-by":"crossref","unstructured":"\u0141usiak-Szelachowska, M., Mi\u0119dzybrodzki, R., Drulis-Kawa, Z., Cater, K., Kne\u017eevi\u0107, P., Winogradow, C., Amaro, K., Jo\u0144czyk-Matysiak, E., Weber-D\u0105browska, B., and R\u0119kas, J. (2022). Bacteriophages and antibiotic interactions in clinical practice: What we have learned so far. J. Biomed. Sci., 29.","DOI":"10.1186\/s12929-022-00806-1"},{"key":"ref_235","doi-asserted-by":"crossref","unstructured":"Ferran, A.A., Lacroix, M.Z., Gourbeyre, O., Huesca, A., Gaborieau, B., Debarbieux, L., and Bousquet-Melou, A. (2022). The selection of antibiotic- and bacteriophage-resistant Pseudomonas aeruginosa is prevented by their combination. Microbiol. Spectr., 10.","DOI":"10.1128\/spectrum.02874-22"},{"key":"ref_236","doi-asserted-by":"crossref","unstructured":"Abedon, S.T. (2019). Phage-antibiotic combination treatments: Antagonistic impacts of antibiotics on the pharmacodynamics of phage therapy?. Antibiotics, 8.","DOI":"10.3390\/antibiotics8040182"},{"key":"ref_237","doi-asserted-by":"crossref","unstructured":"Danis-Wlodarczyk, K.M., Cai, A., Chen, A., Gittrich, M.R., Sullivan, M.B., Wozniak, D.J., and Abedon, S.T. (2021). Friends or foes? Rapid determination of dissimilar colistin and ciprofloxacin antagonism of Pseudomonas aeruginosa phages. Pharmaceuticals, 14.","DOI":"10.3390\/ph14111162"},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"e01341-17","DOI":"10.1128\/mBio.01341-17","article-title":"Associations among antibiotic and phage resistance phenotypes in natural and clinical Escherichia coli isolates","volume":"8","author":"Allen","year":"2017","journal-title":"MBio"},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1111\/eva.12653","article-title":"Rapid evolution of generalized resistance mechanisms can constrain the efficacy of phage-antibiotic treatments","volume":"11","author":"Friman","year":"2018","journal-title":"Evol. Appl."},{"key":"ref_240","doi-asserted-by":"crossref","unstructured":"Kortright, K.E., Doss-Gollin, S., Chan, B.K., and Turner, P.E. (2021). Evolution of bacterial cross-resistance to lytic phages and albicidin antibiotic. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.658374"},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"e0224721","DOI":"10.1128\/aac.02247-21","article-title":"Antibiotic exposure leads to reduced phage susceptibility in vancomycin intermediate Staphylococcus aureus (VISA)","volume":"66","author":"McCallin","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.tim.2021.11.002","article-title":"Targeting bacterial outer-membrane remodelling to impact antimicrobial drug resistance","volume":"30","author":"Rosas","year":"2022","journal-title":"Trends Microbiol"},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"e2216084120","DOI":"10.1073\/pnas.2216084120","article-title":"Antibiotics that affect translation can antagonize phage infectivity by interfering with the deployment of counter-defenses","volume":"120","author":"Pons","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.ijantimicag.2018.09.006","article-title":"Bacteriophage Sb-1 enhances antibiotic activity against biofilm, degrades exopolysaccharide matrix and targets persisters of Staphylococcus aureus","volume":"52","author":"Tkhilaishvili","year":"2018","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.7150\/ijbs.60551","article-title":"A combination therapy of phages and antibiotics: Two is better than one","volume":"17","author":"Li","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"ref_246","doi-asserted-by":"crossref","unstructured":"Liu, C., Hong, Q., Chang, R.Y.K., Kwok, P.C.L., and Chan, H.K. (2022). Phage-antibiotic therapy as a promising strategy to combat multidrug-resistant infections and to enhance antimicrobial efficiency. Antibiotics, 11.","DOI":"10.3390\/antibiotics11050570"},{"key":"ref_247","doi-asserted-by":"crossref","unstructured":"Pirnay, J.-P., Ferry, T., and Resch, G. (2022). Recent progress toward the implementation of phage therapy in Western medicine. FEMS Microbiol. Rev., 46.","DOI":"10.1093\/femsre\/fuab040"},{"key":"ref_248","doi-asserted-by":"crossref","unstructured":"Abedon, S.T. (2023). Bacteriophage adsorption: Likelihood of virion encounter with bacteria and other factors affecting rates. Antibiotics, 12.","DOI":"10.3390\/antibiotics12040723"},{"key":"ref_249","doi-asserted-by":"crossref","unstructured":"Tang, Z., Tang, N., Wang, X., Ren, H., Zhang, C., Zou, L., Han, L., Guo, L., and Liu, W. (2023). Characterization of a lytic Escherichia coli phage CE1 and its potential use in therapy against avian pathogenic Escherichia coli infections. Front. Microbiol., 14.","DOI":"10.3389\/fmicb.2023.1091442"},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.3382\/ps\/pey294","article-title":"Autophage as a control measure for Salmonella in laying hens","volume":"97","author":"Marin","year":"2018","journal-title":"Poult. Sci."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.healun.2022.01.018","article-title":"Bacteriophage therapy as a treatment option for complex cardiovascular implant infection: The German Heart Center Berlin experience","volume":"41","author":"Tkhilaishvili","year":"2022","journal-title":"J. Heart Lung Transplant."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"97","DOI":"10.36610\/j.jsaas.2022.090200097x","article-title":"Bacteriophage cocktail as a substitute for antimicrobials in companion animal dermatology","volume":"9","year":"2022","journal-title":"J. Selva Andin. Anim. Sci."},{"key":"ref_253","doi-asserted-by":"crossref","unstructured":"Johri, A.V., Johri, P., Hoyle, N., Pipia, L., Nadareishvili, L., and Nizharadze, D. (2021). Case report: Chronic bacterial prostatitis treated with phage therapy after multiple failed antibiotic treatments. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.692614"},{"key":"ref_254","doi-asserted-by":"crossref","unstructured":"Harper, D.R., Abedon, S.T., Burrowes, B.H., and McConville, M. (2021). Current updates from the long-standing phage rsearch centers in Georgia, Poland, and Russia. Bacteriophages: Biology, Technology, Therapy, Springer Nature Switzerland AG.","DOI":"10.1007\/978-3-319-41986-2"},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2174\/138920312804871193","article-title":"Learning from bacteriophages\u2014Advantages and limitations of phage and phage-encoded protein applications","volume":"13","author":"Maciejewska","year":"2012","journal-title":"Curr. Protein Pept. Sci."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1751-7915.2011.00259.x","article-title":"Evaluation of lytic activity of staphylococcal bacteriophage Sb-1 against freshly isolated clinical pathogens","volume":"4","author":"Kvachadze","year":"2011","journal-title":"Microb. Biotechnol."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2174\/138920110790725401","article-title":"Phage therapy in clinical practice: Treatment of human infections","volume":"11","author":"Kutter","year":"2010","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_258","unstructured":"Schaecter, M. (2009). Bacteriophage therapy: Past and present. Encyclopedia of Microbiology, Elsevier."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/8\/1094\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:26:08Z","timestamp":1760034368000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/8\/1094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":258,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["v17081094"],"URL":"https:\/\/doi.org\/10.3390\/v17081094","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,8]]}}}